UPMC
27
23M
18
0.21
9
0.33
6
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Pittsburgh.
Considering the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2013. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this UPMC works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from UPMC is 500 millions - 1 billion dollars.
The overall number of key employees were 3.
We can highlight the next thriving fund investment areas, such as Fitness, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Health Catalyst, medCPU, ALung Technologies The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the UPMC, startups are often financed by Norwest Venture Partners, Uncork Capital, Threshold. The meaningful sponsors for the fund in investment in the same round are Threshold, Froedtert Health, Philips Healthcare. In the next rounds fund is usually obtained by Threshold, Norwest Venture Partners, Froedtert Health.
Investments analytics
Analytics
- Total investments
- 27
- Lead investments
- 9
- Exits
- 6
- Rounds per year
- 0.21
- Follow on index
- 0.33
- Investments by industry
- Health Care (24)
- Information Technology (9)
- Software (8)
- Medical Device (5)
- Medical (5) Show 23 more
- Investments by region
-
- United States (25)
- Israel (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 84M
- Group Appearance index
- 0.81
- Avg. company exit year
- 10
- Avg. multiplicator
- 3.68
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Everna | 23 Sep 2019 | Biotechnology, Medical, Pharmaceutical | Seed | England, London, United Kingdom | |
Werewolf Therapeutics | 20 Nov 2019 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 56M | United States, Massachusetts, Cambridge |
Xealth | 27 Mar 2019 | Health Care, Health Diagnostics, Personal Health, Therapeutics | Early Stage Venture | 11M | United States, Washington, Seattle |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.